
KalVista Pharmaceuticals to Showcase Data at 2024 ACAAI Annual Scientific Meeting
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) has announced that five of its abstracts have been accepted for e-Poster presentations at the 2024 Annual Scientific Meeting of the American College of Allergy,…












